At the Neurology Institute, we provide comprehensive evaluation, diagnosis, and advanced treatment for the full spectrum of neurological disorders. Our team combines expert clinical leadership with state-of-the-art neurodiagnostic technology to deliver exceptional patient care.
The Neurology Institute provides specialized evaluation and long-term management of Multiple Sclerosis and related demyelinating diseases under the leadership of Prof. Yamout, President of MENACTRIMS.
Services include:
A specialized center dedicated to the accurate diagnosis and expert management of all headache disorders.
Headache and migraine are among the most common neurological conditions and can significantly impact daily life.
We provide comprehensive, expert-led evaluation focusing on each patient’s unique headache pattern and triggers.
We treat:
We manage all types of neuropathies including sensory, motor, small-fiber neuropathy, diabetic neuropathy, chemotherapy-induced neuropathy, entrapment neuropathies, autoimmune neuropathies, and neuropathic pain syndromes.
Specialized evaluation for memory loss, cognitive decline, concentration difficulties, early Alzheimer’s disease, MCI, dementia, and post-illness cognitive issues.
Comprehensive assessment for first-time seizures, recurrent seizures, focal and generalized epilepsy, nocturnal events, absence seizures, childhood epilepsy, and non-epileptic events.
Our unit provides advanced evaluation of brain, nerve, and muscle function.
Electroencephalography (EEG)
Records brain electrical activity for seizure and epilepsy assessment.
Nerve Conduction Studies (NCS)
Measures nerve signal speed and strength to identify neuropathy or nerve compression.
Electromyography (EMG)
Assesses muscle electrical activity and nerve–muscle function.
Evoked Potentials (EP)
A non-invasive method assessing brain and spinal cord responses:
Dedicated neurological care for infants, children, and adolescents.
We treat developmental delay, autism, ADHD, pediatric epilepsy, tics, neuromuscular disorders, pediatric migraine, and speech/language delay.